The prerequisite(s) for this Teaching Unit (Unité d’enseignement – UE) for the programmes/courses that offer this Teaching Unit are specified at the end of this sheet.
At the end of this learning unit, the student is able to :
At the end of this teaching entity, the student will have acquired knowledge of the basic concepts in pharmacology: 1. He will be able to define the main targets of the drugs and understand the methods used to determine their activity. 2. He will have an integrated vision of intracellular signaling pathways. 3. He will be able to understand the multiplicity of targets used or usable in pharmacology. 4. He will dispose of general notions concerning the use of medicinal products in human medicine and in particular the principle of studies leading to their validation.
The contribution of this Teaching Unit to the development and command of the skills and learning outcomes of the programme(s) can be accessed at the end of this sheet, in the section entitled 'Programmes/courses offering this Teaching Unit'.
- General pharmacotherapy: therapeutic index; Tolerance and drug dependence; side effects; Drugs interactions; Clinical evaluation of drugs: placebo effect, clinical trials.
- Systematic description of pharmacological targets at the molecular level and their implications in various pathophysiological processes
The teaching is essentially based on the exploration of a large number of notions specific to pharmacology. Beyond a descriptive theoretical course, the notions are developed through concrete examples.
Due to the COVID-19 crisis, the information in this section is particularly likely to change.Teaching is based on lectures (total of 30 hours) and practical work in laboratory (7.5 hours)
Due to the COVID-19 crisis, the information in this section is particularly likely to change.Oral examination. The student is allowed to individually prepare the exam before the oral examination.